Diffuse and Localized Pigmented Villonodular Synovitis: Evaluation of Treatment of 38 Patients
Overview
General Surgery
Orthopedics
Affiliations
We performed a retrospective study of 38 patients with pigmented villonodular synovitis (PVNS) to evaluate the treatment and functional results. The mean age of the patients was 32 (range 12-72) years at the time of treatment. Three types of PVNS have been identified: localized nodules in 9 patients, diffuse PVNS of the entire synovial membrane in 26, a combination of a diffuse involvement of the synovial membrane and an extra-articular presentation in 1, and extra-articular lesions in 2. The location of the lesions was knee (n = 31), hip (n = 3), ankle (n = 2), femoral triangle (n = 1), and gluteal region (n = 1). The procedures performed were surgery alone, surgery combined with radiosynovectomy and radiosynovectomy only. A follow-up was done after a mean of 4 (range 1-19) years in 34 patients. A functional evaluation according to the Musculoskeletal Tumor Society was performed in 31 patients. The mean functional evaluation score of 34 patients was 24 (range 15-30). Most of the ratings were excellent or good, in 6 cases fair, and in 2 cases poor. This study demonstrates that the functional results are good despite residual or recurrent disease; in addition, we showed that functional evaluation after treatment gives an optimal view of the impact and results of the operation.
Surgical management of villonodular-pigmented synovitis of knee: decisional algorithm.
Cosseddu F, Ipponi E, Ruinato A, Shytaj S, Capanna R, Andreani L Orthop Rev (Pavia). 2025; 14(5):39644.
PMID: 39949378 PMC: 11823388. DOI: 10.52965/001c.39644.
Babalola Q, Igbinoba B, Eyesan S, Aramide K, Oghenerume M, Onobinoje A J West Afr Coll Surg. 2022; 10(3):45-48.
PMID: 35720950 PMC: 9202604. DOI: 10.4103/jwas.jwas_20_22.
He Q, Zan X, Chen F, You C, Xu J Sci Rep. 2022; 12(1):5763.
PMID: 35388075 PMC: 8987063. DOI: 10.1038/s41598-022-09732-6.
Hip Tenosynovial Giant Cell Tumor without Recurrence in a 9-Year Follow-Up.
Kazemi S, Hosseininejad S Case Rep Orthop. 2022; 2022:1797218.
PMID: 35154840 PMC: 8837448. DOI: 10.1155/2022/1797218.
Vaynrub A, Healey J, Tap W, Vaynrub M Onco Targets Ther. 2022; 15:53-66.
PMID: 35046667 PMC: 8763255. DOI: 10.2147/OTT.S345878.